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Abstract – Introduction: Management of malignant tumors of the hand and wrist is challenging and is generally
approached by limb salvage or amputation. With advances in care, amputation has been superseded by limb salvage
as the treatment of choice.
Methods: A narrative literature review was performed to identify articles on the topic of management of soft tissue
tumors of the upper extremity, including surgical management, adjuvant radiation therapy, and chemotherapy.
Results: A total of 29 articles were selected. Earlier reports favored radical tumor resection, which often led to
amputation, whereas later articles demonstrated limb salvage as the preferential treatment modality.
Conclusions: Given the detrimental effects on function and psychologic outcomes, amputation has been superseded by
limb salvage in most cases, although it can occasionally be the only option. A variety of adjuvant therapies have been
described, including radiation or brachytherapy, chemotherapy, and regional hyperthermia. Radiation treatment, and
specifically brachytherapy, is beneficial to select patients. Controversy surrounds chemotherapy in certain subtypes,
and regional hyperthermia requires further investigation.
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Introduction
Most soft tissue tumors in the upper extremity are benign,
and soft tissue sarcomas are rare in the hand and wrist [1].
The primary goal in treating malignant hand tumors is onco-
logic cure, and the secondary goal is maintenance of maximum
function and appearance [2, 3]. Resection should achieve clear
margins, preserve functional length, prevent joint contractures
and neuromas, and minimization of morbidity [2]. Traditional
treatment has focused on amputation, justified by the notion
that overzealous functional preservation would result in
compromise of surgical margins and increased risk of
recurrence [4]. Amputation provides adequate local control,
however it sacrifices function and has significant psychological
consequences [5, 6]. Therefore treatment of extremity tumors,
including hand tumors, has trended toward limb-sparing
surgery combined with radiation therapy [5, 7]. Given the
complex anatomy of the hand and wrist, radical tumor
resection here often means above-the-elbow amputation, thus
highlighting the importance of limb salvage surgery consider-
ations in upper extremity sarcoma [1]. Prior to the 1980s,
amputation was the mainstay of treatment given higher
recurrence with salvage resection, which has since improved
through the implementation of more advanced surgical
techniques [8]. Recently, limb salvage has become the prefer-
ential treatment over amputation [2] and is now considered the
standard of care for soft tissue sarcomas of the extremities [9].
At least 85–95% of soft tissue sarcomas and osteosarcomas are
now treated with limb-sparing methods, thus reconstruction
has become an area of increasing importance [10, 11].
This article attempts to explore current thinking on
treatment of soft tissue sarcomas of the upper extremity and
establish an overview of limb salvage techniques.
Comparison of amputation to limb salvage
Although limb salvage with chemotherapy and radiation is
now considered the standard of care, there are still some
instances where amputation may remain the best method for
cure [2]. Limb salvage is an impractical therapy for larger
and more invasive tumors. Often the simplest method in
reconstruction with rapid wound healing and least complex
coverage is preferred [2]. Amputation is more likely to be*Corresponding author: akulidjian@ucsd.edu
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appropriate when there is tumor involvement into neurovas-
cular structures, anticipated poor functional outcomes, and
patient preference [5]. Some cases would result in improved
functional outcomes with amputation and prosthesis compared
to limited surgery [5]. In some instances, simple amputation
without efforts at complex reconstruction may actually provide
the least morbidity and the fastest return to desired functional
levels [2]. Amputation is also more appropriate in patients who
have had multiple local recurrences in the past [8]. Generally,
amputation is more likely to be appropriate for distal lesions
in which the limitation to function is relatively reduced [1].
In comparing the two options in terms of the primary goal
of oncologic cure, the rate of local recurrence was initially
higher in patients who had limb salvage over amputation
[12], however survival was equivalent [7, 13]. The initial local
control rate seemed improved in amputation, however the
overall survival did not improve thus indicating that modern
limb salvage is equivalent to amputation in terms of survival
[8]. These developments resulted in increased use of limb
salvage with increasing reliance on adjuvant therapy [7].
These initially higher recurrence rates with limb salvage
compared to amputation were likely due to more primitive
techniques of early limb salvage therapy [8]. While amputation
still results in lower recurrence rates, the observed benefit
diminishes as limb salvage techniques improve. Now, limb
salvage is used in the majority of patients with extremity
sarcomas without increased rates of recurrence, metastasis,
or death compared to amputation [11].
Overall, limb salvage often provides good functional
outcome [6]. Further studies have also demonstrated that
limited surgery with functional sparing in addition to radio-
therapy can provide adequate local control and survival [5].
Local control with limited surgery is highly dependent and
significantly improved with adequate surgical resection, such
that adjuvant or neoadjuvant therapy does not compensate
for inadequate margins [5, 14]. It is also important to remem-
ber that radiotherapy carries the risk of complications of
nearby structures, thus impairing function, which can be
reduced through careful planning [4]. Radiotherapy is associ-
ated with improved local control after surgical resection
without effect on overall survival [5]. In terms of functional
outcomes, some studies have demonstrated that radiotherapy
has a detrimental effect in the hand as measured by the grip
strength [15], while others have noted no change in functional
scores [6]. Limb salvage with adjuvant radiation therapy of
upper extremity sarcomas results in 85–95% sustained local
control, and 5-year survivals of 75–80% [1]. A summary of
findings from the literature can be found in Table 1.
Reconstruction
In terms of maintaining maximal function, limb salvage
surgery is advantageous, and may require soft tissue and
neurovascular reconstruction. Reconstruction can either be
performed at the time of resection or staged after a short inter-
val, usually if there is concern about inadequate margins [16].
Repair warrants important considerations, including defect
size, timing of reconstruction, defect location, neurovascular
structure, patient functional status, scar contracture, and the
benefits of avoiding multiple surgical procedures [10].
Following resection, reconstruction options are many, includ-
ing primary closure, skin grafting, local soft tissue flaps, regio-
nal pedicle and island flaps, free tissue transfer, composite free
tissue transfer, allografts, endoprostheses, and tendon, nerve,
or arterial grafting [10]. These options are discussed below.
Generally, reconstruction should be attempted in the
simplest possible method [11]. The approach to reconstruction
generally starts with vascular reconstruction, followed by
establishing a stable bony skeleton, followed by reconstruction
of critical nerves and tendons [11]. Reconstruction of these
structures, when performed immediately following tumor
resection, allows for fewer surgeries, earlier mobilization,
and a faster recovery [11]. When severing nerves, truncation
of nerves proximally helps to avoid neuroma formation at
the stump [2].
The most basic option in reconstruction is primary closure,
which is highly dependent on the size of the defect created by
the resection and limits of tension [10, 11]. Primary closure
can be used for small defects, however repair under tension,
which is more likely to occur with larger defects, will often
result with wound contracture and subsequent decreased
functional outcomes [10]. Flaps and skin grafts avoid this
problem. Local flaps can mitigate this issue, such as Z-plasty
and rhomboid flaps, whose main benefits are to increase length
of the scar and decrease tension, respectively [10]. The theory
of a Z-plasty is to rotate the axis of contracture away from the
plane of maximum tension and lengthens the scar by recruiting
local tissue excess [10]. Larger angles used in Z-plasties
lead to larger gains in length at the expense of tension [10].
With skin grafting in relation to the hand, full-thickness grafts
are preferred due to increased limits of wear and decreased
rates of contraction [10] as well as improved cosmetic out-
comes [11]. Rotational flaps allow spreading of tension over
a larger area [10]. Advancement flaps are often used in
fingertip amputations or on the dorsum of the hand, and given
their local nature, result in excellent color and texture matching
[10]. Free flaps are useful when skin grafting or local flaps
would cause undesirable results. Disadvantages of this
approach include the possibility of flap failure and the
prolonged operating times [10]. Commonly used free flaps
include the rectus free flap, scapular free flap, latissimus dorsi
free flap, gracilis free flap, and fibula free flap [10]. The fibula
free flap is useful when significant amounts of vascularized
bone are required for reconstruction [10]. Caution must be
exercised when proceeding with complicated coverage and
flaps, as this adds stress on the blood supply to an area which
may require radiation, thus impeding healing [2]. The most
important factor in flap survival is surgical experience [10].
Pedicle flaps warrant careful consideration in oncologic
cases given the concerns for tumor seeding adjacent regions
resulting in local recurrence [1, 2].
Partial hand amputations, such as single or double ray
amputations, can provide oncologic cure while maintaining
good functional outcomes [15]. Ray amputations (Figure 1)
are often necessary to achieve negative margins in the manage-
ment of sarcomas of the hand [4]. In addition to adequate
control, ray amputations also provide acceptable functional
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Table 1. Literature overview.
Title Authors Number
of cases
Treatment
modalities
Mean follow-up
(years)
Oncologic outcome
Amputation for extremity soft tissue
sarcoma does not increase overall
survival: A retrospective cohort
study
Alamanda
et al.
278 LSS vs. amputation 3.1 No difference between
mortality, distant
metastases, and local
recurrence
Long-term outcome after local
recurrence of soft tissue sarcoma:
a retrospective analysis of factors
predictive of survival in 135 patients
with locally recurrent soft tissue
sarcoma
Daigeler
et al.
135 LSS with or without
adjuvant chemo
and/or radiation
12.3 Significant prognostic
indicators for post-
resection survival were
histologic grade, tumor
site, time to initial
recurrence, the number of
recurrences, and the
surgical margin status
attained at the last
resection.
Neoadjuvant Chemotherapy and
Radiotherapy for Large Extremity
Soft Tissue Sarcomas
DeLaney
et al.
48 Adjuvant chemo and
radiation vs. no
adjuvant treatment
4 Gain in disease-free and
overall survival compared
with a historical control
group
Recurrent aggressive chondrosarcoma
of the middle phalanx of the index
finger: excision and reconstruction
with an osteocartilaginous allograft
Exner
et al.
1 LSS 12 Digit-sparing techniques may
be considered rather than
ablative procedures
A randomized phase II study on
neo-adjuvant chemotherapy for
‘high-risk’ adult soft tissue
sarcoma
Gortzak
et al.
134 Amputation or LSS with
or without
chemotherapy
7.3 Neo-adjuvant chemotherapy
does not negatively affect
the ability to perform
surgery
Neo-adjuvant chemotherapy alone
or with regional hyperthermia
for localized high-risk soft tissue
sarcoma: a randomized phase III
multicenter study
Issels et al. 341 Neoadjuvant
chemotherapy
with or without
regional hypothermia
2.8 Regional hyperthermia
increases the benefit of
chemotherapy
Squamous Cell Carcinoma of the
Skin of the Trunk and Limbs:
The Incidence of Metastases
and Their Outcome
Joseph et al. 695 LSS or amputation 4 Risk factors associated with
the development of
metastatic disease were:
delayed presentation: large
neglected lesions:
misdiagnosis; and multiple
treatments to the primary
lesion
Limb Salvage Surgery and Adjuvant
Radiotherapy for Soft Tissue
Sarcomas of the Forearm and Hand
Bray et al. 25 LSS or amputation 3.1 Limb salvage surgery, with
adjuvant radiotherapy
when necessary, is an
effective alternative to
amputation in the majority
of patients with sarcoma of
the forearm and hand.
Localized Operable Soft Tissue
Sarcoma of the Upper Extremity
Collin et al. 108 LSS or amputation 8.2 Predictors of local failure:
presentation with local
recurrence, surgery by
LSS, inadequate margins,
angiosarcoma, and
invasion of vital structures.
Primary reconstruction with digital
ray transposition after resection
of malignant tumor
Muramatsu
et al.
4 Digital ray transposition
after tumor resection
6.9 Primary reconstruction with
digital ray trans position
produces acceptable
functional outcomes after
resection of malignant
tumor.
(continued on next page)
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outcomes, however emotional acceptance of a three-fingered
hand may be deemed unsatisfactory by some patients [17].
Given the specialized nature of palmar skin, reconstruction is
particularly challenging [10]. The dorsum of the hand is more
forgiving given the axial blood supply and loose skin, thus
allowing moderately sized defects to be closed primarily
[10]. In digit reconstruction, goals include maintenance of
sensation, length, and flexibility [10]. In these instances,
defects as large at 1 cm undergo satisfactory healing by
secondary intention [10]. Skin grafts can be used for both
temporary and definitive treatment options, however with a
major drawback of lack of sensation [10]. In soft tissue
sarcomas of the distal digits, adequate surgical margins
are usually obtained by disarticulations at the distal
interphalangeal joint (DIP) or proximal interphalangeal (PIP)
joints [1].
Limb salvage often creates complex soft tissue defects that
are prone to difficulties in wound healing [9]. It is generally
assumed that patients undergoing flap reconstruction, which
is considered to be the most complex form of reconstruction,
will have increased morbidity given the added complexity of
this treatment modality [9]. This assumption is based on the
hurdles, such as vascular vulnerability and donor/recipient site
morbidity [9], brought about by flap reconstruction. However,
there is conflicting data regarding the impact of flap
reconstruction on the rate of complications following limb
Table 1. (continued)
Title Authors Number
of cases
Treatment
modalities
Mean follow-up
(years)
Oncologic outcome
Preoperative versus postoperative
radiotherapy in soft tissue sarcoma
of the limbs: a randomized trial
O’Sullivan
et al.
190 Preoperative radiation vs.
postoperative radiation
3.3 Choice of regimen for
patients with soft tissue
sarcoma should take into
account the timing of
surgery and radiotherapy,
and the size and
anatomical site of the
tumor
Outcomes after flap reconstruction
for extremity soft tissue sarcoma:
A case-control study using
propensity score analysis
Kang et al. 148 Flap reconstruction vs.
primary closure
5.4 Flap reconstruction had
increased morbidity
associated with flap
reconstruction, but better
local control, when
compared to patients with
primary closure
Chondrosarcoma of Small Bones
of the Hand
Patil et al. 23 Curettage, excision, ray
resection/amputation
8.5 Results show a high rate of
recurrence following
curettage, therefore it
cannot be recommended
for most patients
Single Ray Amputation for Tumors
of the Hand
Puhaindran
et al.
25 Ray amputation with or
without radiotherapy
3 Single ray amputation for
hand tumors has low
recurrence rates and high
functional scores
Treatment of Soft Tissue Sarcomas
of the Extremity
Rosenberg
et al.
43 LSS vs. amputation 3 LSS, radiation therapy, and
adjuvant chemotherapy are
capable of successfully
treating the majority of
adult patients with soft
tissue sarcomas of the
extremity
Standardization of rehabilitation
after limb salvage surgery for
sarcomas improves patients’
outcome
Shehadeh
et al.
59 LSS 2 Use of standardized
rehabilitation protocol
resulted in improved
patient functional outcome
Functional and oncological
outcomes after limb salvage
surgery for primary sarcomas
of the upper limb
Wright
et al.
72 LSS with or without
adjuvant chemotherapy
and/or radiotherapy
2.8 Limb salvage surgery is
applicable to a wide range
of tumor types and grades,
to all patient age groups,
and anatomical sites with
good functional results
* LSS = limb salvage surgery.
4 K.T. Jubbal et al.: SICOT J 2017, 3, 47
(A) (D)
(B)
(C)
(E)
Figure 1. (A) Squamous cell carcinoma of the left hand near the interdigital web space between the third and fourth metacarpals. (B, C)
Preoperative markings at volar and dorsal aspects. (D) Intraoperative ray resection with filet flap preserved from disease-free zone for
coverage of soft tissue defect. (E) After ray resection and incision closure with filet flap.
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salvage surgery [9]. Interestingly, patients with soft tissue
sarcoma of the extremities were found to have lower recur-
rence rates with flap reconstruction than primarily closure,
which may be attributable to wider surgical margins used with
flap reconstruction in comparison to primary closure [9].
Radiation
Adjuvant radiation, although effective in improving local
control after resection, is not necessary or necessarily
beneficial in all patients [5]. Radiotherapy is less likely to be
necessary in those patients with small low-grade lesions that
are resected with widely negative margins [5]. Benefits of
radiation are more likely to be appreciated when patients
present with high-grade lesions, large lesions, or borderline
or positive margins [5]. In cases where limb salvage and
external beam radiation are used, the benefits of preoperative
versus postoperative radiation have been debated [1, 18].
Preoperative radiation has a few benefits: first, there is a higher
rate of margin-negative resection in large tumors or those in
close proximity to vital structures [5]. This is due to tumor
necrosis which reduces tumor size and resultant tumor contam-
ination during surgery [1]. Second, the doses used tend to be
lower and radiation fields smaller, thus limiting damage to
normal tissue [1, 5, 18]. Overall, these factors result in lower
long-term toxicity seen with the preoperative approach [5].
The disadvantages of the preoperative approach include higher
wound complication rates [18], with one study finding quadru-
ple the wound complication rate [19]. As a result, preoperative
radiation is primarily reserved for those whose tumor location
is prohibitive of wide resection techniques, such as those near
neurovascular structures [1]. Despite the theoretical advantages
and disadvantages, no survival benefit has been demonstrated
between preoperative and postoperative external beam
radiation [1, 18].
Attempting to preserve important neurovascular and other
functional structures in limb-sparing procedures may compro-
mise the adequacy of surgical margins, resulting in increased
risk of local recurrence [4]. Previous radiotherapy to a recipient
or donor site in flap procedures may influence vascular
availability [10]. Invasion into critical neurovascular struc-
tures complicates limb salvage and often leads to poorer
outcomes [8] as well as higher rates of recurrence [7]. Healing
by secondary intention when adjuvant radiation is used is more
likely to result in chronic non-healing wounds [2]. Radiation
exposure to adjacent normal tissue can be further decreased
with brachytherapy [5]. Postoperative brachytherapy, through
sparing of adjacent normal tissue, results in decreased
complications such as edema and stiffness, with delayed
initiation of radiation further lowering complication rates [1].
Perioperative brachytherapy results in better local control than
surgery alone with high-grade lesions [16].
Chemotherapy
The use of adjuvant chemotherapy remains controversial
[1, 5]. The recurrence rates with adjuvant chemotherapy are
reduced, however the presence and duration of benefits remains
unsettled [5]. Neoadjuvant chemotherapy provides the
theoretical advantages of control of micrometastatic disease
as well as facilitating resection of the primary tumor [20].
Those with high-risk metastatic disease, including large,
high-grade, and deep lesions, are more likely to benefit from
chemotherapy [5]. More favorable results have been reported
with neoadjuvant use of certain agents, especially when
combined with radiation therapy [1]. DeLaney found improved
5-year survival using preoperative mesna, adriamycin,
ifosfamide, and dacarbazine (MAID therapy) combined with
radiation therapy compared to postoperative radiation therapy
alone [20]. A separate randomized phase II study was unable
to demonstrate survival benefit with neo-adjuvant chemother-
apy after seven years [21].
Additional therapies, such as regional hyperthermia, can be
used as both a radiosensitizer and a chemosensitizer by causing
direct thermal toxicity, increasing drug efficacy, and inducing
tumoricidal immune responses [22, 23]. In combination with
neo-adjuvant chemotherapy, it has been demonstrated to
increase benefits of neo-adjuvant chemotherapy [23].
Oncological subtypes
The most common subtypes of sarcoma in the upper
extremity include synovial sarcomas, epithelioid sarcomas,
clear cell sarcomas, and malignant fibrous histiocytomas
[1, 5]. Extremity sarcomas generally present with localized dis-
ease, however 10% present with metastatic involvement which
is primarily in the lung, lymph nodes, and bone [5]. Factors
that increase the risk of metastases include larger size, deep
to superficial fascia, high-grade tumors, and high-risk
histologic subtypes [5]. Recurrence in extremity locations
has a significantly better prognosis compared to non-extremity
lesions [24]. Other factors in recurrent disease associated with
improved survival include late recurrence and low histologic
grade [24]. In recurrent disease, the effect of adequate versus
inadequate surgical margins has increased impact [24].
Cases in which re-excision was performed resulted in poorer
outcomes compared to those that underwent primary wide
resections [4]. It is important to note that in metastatic disease,
malignant cells invade the blood vessels to reach distant site
[8]. In these cases, amputation will control local disease,
however it is unable to change the course of these malignant
cells when migration has already taken place [8]. The site of
biopsy becomes very important, as the needle can seed tumor
cells contributing to local recurrence if the biopsy site and tract
is not excised during definitive surgery [5]. Additionally,
biopsy incisions should be placed longitudinally to better
accommodate proper resection and minimal violation of
surrounding normal tissues [1, 5].
Overall survival and long-term outcomes of sarcomas are
dependent on histologic grade, depth, tumor size, and
histologic subtype [24]. Tumor size is an important factor in
predicting metastasis-free survival and overall survival [5].
Often distal masses are identified sooner and are therefore
smaller on presentation [5]. Those tumors which lie deep have
a worse prognosis than superficial tumors [5]. As expected,
local treatment failure rates increase as the margin size
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decreases [7]. In fact, the presence of positive margins is the
most important factor in predicting recurrence [5]. However,
it has been suggested that rather than positive margin
status, the inherent aggressiveness of the tumor is more
indicative of the final outcome, meaning that margin status is
a result of biological aggressiveness rather than a cause [24].
In accordance with this, Daigeler found similar survival
between certain individuals with residual tumor compared to
those with complete resection and negative margins [24].
Based on these findings, it seems negative margins provide
long-term benefit in patients with locally recurrent soft tissue
sarcomas, however achievement of negative margins at all
costs (including amputation in cases where salvage is not
possible) may not be necessary and should be tailored to
individual cases [24].
Chondrosarcoma accounts for about 4% of hand
tumors [25, 26] and 40% of malignant bone tumors of the
hand, yet despite their rare occurrence, they are the most
common malignant bone tumor in the hand [3, 11]. Primary
chondrosarcoma of the hand and wrist usually arises de
novo, however malignant degeneration of a preexisting lesion,
such as those with enchondromatosis or osteochondromatosis,
may occur as well [3, 27].
The optimal treatment approach of chondrosarcoma is not
clear based on differing information on recurrence rates.
Chondrosarcoma of the hand is usually aggressive and high-
grade, however the phalangeal form is characterized by local
recurrence [25] and minimal metastatic potential in contrast
to chondrosarcomas located elsewhere [3]. The reason for this
variable behavior has been postulated to be due to the small
size of hand tumors, low temperature in the digits, or differ-
ences in tumor development [26]. Despite the more benign
nature of chondrosarcomas in the hand, optimal treatment is
not clear.
Traditional advice for treatment has gravitated toward ray
resection or digital amputation with wide margins to prevent
local recurrences (Figure 2) [26]. Treatment of chondrosar-
coma was previously wide en bloc excision either through limb
salvage or amputation [27], however recent literature
advocates intralesional excision with close follow-up [3].
Amputation or ray resection results in excellent local control,
while a significant rate of local recurrence has been reported
in patients with curettage or local excision [27]. Due to its
more benign nature, some researchers suggest that a more
conservative surgical approach is warranted to preserve
function (Figure 3) [25, 28]. This approach is supported by
similar survival rates between both amputation and curettage
with adequate follow-up, thus suggesting that limb-sparing
procedures should take precedence, especially in cases where
amputation would lead to a significant loss of hand function
[29]. However, others suggest the more traditional approach
of ray resection or digital amputation, except in exceptional
circumstances such as old and frail patients, due to other
differing results demonstrating a higher rate of recurrence fol-
lowing curettage [26].
Chondrosarcomas of the phalanges are generally less
aggressive than chondrosarcomas located to the metacarpals
and metatarsals [28]. In those patients with high risk for local
recurrence, reconstruction using total allograft replacement of
the phalanx is an important option to consider, as removal of
the total bone offers a higher chance of cure [28].
Summary
In the treatment of upper extremity sarcoma, the main
treatment distinction is between limb salvage and amputation.
Given the detrimental effects on function and psychologic
outcomes, amputation has been superseded by limb salvage
in most cases, although it can occasionally be the only option.
(A) (B)
(C) (D)
Figure 2. (A) Chondrosarcoma of the left hand at the second
metacarpal and proximal phalanx. (B) Status post-ray amputation of
the involved index finger with preservation of a filet flap from the
distal uninvolved tissue from the amputated index finger to
(C) cover the soft tissue defect after tumor resection.
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Radiation therapy reduces recurrence, although preoperative
and postoperative radiation carry unique benefits and risks.
Brachytherapy is beneficial to patients with high-grade lesions.
The use of chemotherapy outside of certain subtypes
remains controversial. Regional hyperthermia is an emerging
therapy which appears beneficial as a radiosensitizer and
chemosensitizer, although further investigation is warranted.
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